These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

424 related items for PubMed ID: 24927265

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Cutting the cord from myelodysplastic syndromes: chronic myelomonocytic leukemia-specific biology and management strategies.
    Padron E, Steensma DP.
    Curr Opin Hematol; 2015 Mar; 22(2):163-70. PubMed ID: 25575034
    [Abstract] [Full Text] [Related]

  • 3. [Chronic myelomonocytic leukemia (CMML): recent advances in molecular pathogenesis and treatment].
    Harada Y, Harada H.
    Rinsho Ketsueki; 2016 Feb; 57(2):147-55. PubMed ID: 26935632
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The division of chronic myelomonocytic leukemia (CMML)-1 into CMML-0 and CMML-1 according to 2016 World Health Organization (WHO) classification has no impact in outcome in a large series of patients from the Spanish group of MDS.
    Xicoy B, Triguero A, Such E, García O, Jiménez MJ, Arnán M, Bernal T, Diaz-Beya M, Valcárcel D, Pedro C, Ramos F, Amigo ML, Collado R, Palomo L, Ardanaz MT, Cedena MT, Grau J, Zamora L, Sanz G.
    Leuk Res; 2018 Jul; 70():34-36. PubMed ID: 29775844
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Clinical spectrum, outcome and management of immune thrombocytopenia associated with myelodysplastic syndromes and chronic myelomonocytic leukemia.
    Jachiet V, Moulis G, Hadjadj J, Seguier J, Laribi K, Schleinitz N, Vey N, Sacre K, Godeau B, Beyne-Rauzy O, Bouvet R, Broner J, Brun N, Comont T, Gaudin C, Lambotte O, Le Clech L, Peterlin P, Roy-Peaud F, Salvado C, Versini M, Isnard F, Kahn JE, Gobert D, Adès L, Fenaux P, Fain O, Mekinian A.
    Haematologica; 2021 May 01; 106(5):1414-1422. PubMed ID: 33626866
    [Abstract] [Full Text] [Related]

  • 16. Current management of patients with chronic myelomonocytic leukemia.
    Alfonso A, Montalban-Bravo G, Garcia-Manero G.
    Curr Opin Oncol; 2017 Jan 01; 29(1):79-87. PubMed ID: 27849645
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Chronic myelomonocytic leukemia: 2013 update on diagnosis, risk stratification, and management.
    Parikh SA, Tefferi A.
    Am J Hematol; 2013 Nov 01; 88(11):967-74. PubMed ID: 23963888
    [Abstract] [Full Text] [Related]

  • 19. How I diagnose and treat chronic myelomonocytic leukemia.
    Patnaik MM.
    Haematologica; 2022 Jul 01; 107(7):1503-1517. PubMed ID: 35236051
    [Abstract] [Full Text] [Related]

  • 20. CMML: a biologically distinct myeloproliferative disease.
    Cortes J.
    Curr Hematol Rep; 2003 May 01; 2(3):202-8. PubMed ID: 12901341
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.